Opens in a new tab

With us, tissue is not an issue

Human heart, skeletal muscle and kidney models, measured automatically on the DiNAQUBE™.

See how it works
Futuristic interior with circular portal and minimalist podium.
Clients
Partners

We are a clinical research organization and develop life science tools

To help you research more effortlessly 
with 3D human tissue technology

The EHT¹ workflow

Manual tissue analysis is a thing of the past. That’s a promise.
Learn more about EHT technology
Abstract blue molecule with transparent bubbles background.

01Engineer Human Tissue

Tap to read more

01Engineer Human Tissue

Tap to read less

Heart (EHT), skeletal muscle (EMT) and kidney organoids from control, patient-derived or gene-edited hiPSC lines.

Engineered Heart Tissues (EHTs) are three-dimensional, fibrin-based cardiac constructs derived from human induced pluripotent stem cells (hiPSCs). Our innovative technology combines hiPSCs with 3D tissue engineering to simulate human heart tissues, enabling precise cardiac safety and efficacy testing, disease modeling and precision medicine including gene therapy applications.

EHTs not only facilitate the rapid translation of research findings into preclinics but also provide a powerful testbed for personalized medicine approaches.

Modern laboratory equipment with sample tray open.

02Run sterile tests in 90 seconds

Tap to read more

02Run sterile tests in 90 seconds

Tap to read less

With the DiNAQUBE™, our AI-driven measurement platform, research has never been more effortless. In just 90 seconds, you can run sterile, video-optical measurements that allow for long-term, non-invasive studies.

The DiNAQUBE™ enables the simultaneous analysis of up to 24 Engineered Heart Tissues (EHTs) per run, combining contractility measurements, electrical pacing, and fluorescence-based readouts such as calcium transients. This comprehensive approach allows you to capture essential time-dependent effects, while our automated tissue recognition technology ensures accurate, reproducible, and user-independent results.

Abstract purple bell curve with time percentage markers.

03Interpret ready-to-use data

Tap to read more

03Interpret ready-to-use data

Tap to read less

With DiNALYTIQS™, our web-based data analytics solution. Designed for ease of access and use, you can effectively retrieve and analyze human tissue data measured with our DiNAQUBE™. Features such as customizable reporting, automated quality control through AI, and integration with multiple data sources allow you to focus more on data interpretation and less on data management.

In addition, AI capabilities simplify and accelerate the classification and comparison of measurements, providing valuable insights and ensuring consistency in data quality and analysis.

Integrates omics and stores GLP-compliant data on-prem or in DiNACLOUD™.

SPOTLIGHT · HFpEF

Human HFpEF in a dish. Diastolic dysfunction you can measure.
Heart failure with preserved ejection fraction is one of cardiology’s largest unmet needs, and animal models capture only parts of it. Our HFpEF engineered heart tissues show impaired relaxation in human tissue, measured on 24 tissues in parallel at any paced rate.
Talk to a scientist
Force curve: control vs. HFpEF engineered heart tissue

About us

Trust those with a legacy in leading edge technology
Our expertise is based on 30 years of research in Engineered Heart Tissue (EHT) technology. Today, our know-how goes beyond biology to data specialization. Allowing us to create technologies that simplify research. To implement in labs or extend teams with our expertise.
“We aim to make the human body measurable. One organ at a time.
Started with the heart. Now heart, muscle and kidney.”
Smiling woman with white blouse, professional headshot.
Alexandra Rhoden, PhD
Chief Executive Officer
More about the DiNABIOS way
Scientist pipetting samples in laboratory.

You choose how we serve you best

Your team’s extension or as in-house platform

from our lab

Services for early-stage drug development
Our versatile screening and phenotyping packages offer everything from drug discovery, safety and efficacy testing to detailed molecular biology insights.
Discover our services

in your lab

The DiNAQUBE™
Enhance your lab’s capabilities with the DiNAQUBE™, our state-of-the-art technology for drug discovery, safety, and efficacy testing.
Meet the DiNAQUBE™
Industrial gray machinery component with control boxModern kiosk terminal with touchscreen display.

More to explore

Updates, Insights & Careers
View all of our publications and open positions

DiNAQUBE™: Automated Contractility Measurement

PDF · September 2026
24 Tissues in 90 s
GLP-Compliant
AI-Driven Analysis
Flyer

Engineered Heart Tissue (EHT) Model

PDF · September 2026
Disease Modelling
Safety & Efficacy
HFpEF
Flyer

Engineered Muscle Tissue (EMT) Model

PDF · September 2026
Skeletal Muscle
Drug Screening
Patient-Specific
Flyer

Human Kidney Organoids

PDF · September 2026
Nephrotoxicity
Disease Modelling
ADPKD
Flyer

DiNABIOS Joins the MAGIC Consortium as an Associated Partner

10th August 2026
Gene Therapy
Human-Centric
Horizon Europe
Press Release

DiNABIOS Applauds Senate Passage of FDA Modernization

29th January 2026
Modernization
Human-Centric
Press Release

DiNAQUBE™: Automated Contractility Measurement

PDF · September 2026
24 Tissues in 90 s
GLP-Compliant
AI-Driven Analysis
Flyer

Engineered Heart Tissue (EHT) Model

PDF · September 2026
Disease Modelling
Safety & Efficacy
HFpEF
Flyer

Engineered Muscle Tissue (EMT) Model

PDF · September 2026
Skeletal Muscle
Drug Screening
Patient-Specific
Flyer

Human Kidney Organoids

PDF · September 2026
Nephrotoxicity
Disease Modelling
ADPKD
Flyer

DiNABIOS Joins the MAGIC Consortium as an Associated Partner

10th August 2026
Gene Therapy
Human-Centric
Horizon Europe
Press Release

DiNABIOS Applauds Senate Passage of FDA Modernization

29th January 2026
Modernization
Human-Centric
Press Release

DiNAQUBE™: Automated Contractility Measurement

PDF · September 2026
24 Tissues in 90 s
GLP-Compliant
AI-Driven Analysis
Flyer

Engineered Heart Tissue (EHT) Model

PDF · September 2026
Disease Modelling
Safety & Efficacy
HFpEF
Flyer

Engineered Muscle Tissue (EMT) Model

PDF · September 2026
Skeletal Muscle
Drug Screening
Patient-Specific
Flyer

Human Kidney Organoids

PDF · September 2026
Nephrotoxicity
Disease Modelling
ADPKD
Flyer

DiNABIOS Joins the MAGIC Consortium as an Associated Partner

10th August 2026
Gene Therapy
Human-Centric
Horizon Europe
Press Release

DiNABIOS Applauds Senate Passage of FDA Modernization

29th January 2026
Modernization
Human-Centric
Press Release